0001592342-17-000003.txt : 20171220
0001592342-17-000003.hdr.sgml : 20171220
20171220141723
ACCESSION NUMBER: 0001592342-17-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20171220
DATE AS OF CHANGE: 20171220
EFFECTIVENESS DATE: 20171220
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vitruvias Therapeutics, Inc.
CENTRAL INDEX KEY: 0001592342
IRS NUMBER: 463308985
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-301275
FILM NUMBER: 171266469
BUSINESS ADDRESS:
STREET 1: 670 NORTH COLLEGE STREET
STREET 2: SUITE B
CITY: AUBURN
STATE: AL
ZIP: 36830
BUSINESS PHONE: 334-647-1948
MAIL ADDRESS:
STREET 1: 670 NORTH COLLEGE STREET
STREET 2: SUITE B
CITY: AUBURN
STATE: AL
ZIP: 36830
FORMER COMPANY:
FORMER CONFORMED NAME: Vitruvias Therapeutics, LLC
DATE OF NAME CHANGE: 20131119
D
1
primary_doc.xml
X0708
D
LIVE
0001592342
Vitruvias Therapeutics, Inc.
670 NORTH COLLEGE STREET
SUITE B
AUBURN
AL
ALABAMA
36830
334-329-5601
DELAWARE
Vitruvias Therapeutics, LLC
Corporation
true
2013
Carl
L
Whatley
670 North College Street
Suite B
Auburn
AL
ALABAMA
36830
Executive Officer
Director
Bryce
M
Harvey
110 Courtyard Circle
Santa Rosa Beach
FL
FLORIDA
32429
Executive Officer
Director
Roger
D
Graben
670 North College Street
Suite B
Auburn
AL
ALABAMA
36830
Executive Officer
Director
A
Stuart
Hendon
2613 Aimee Drive
Montgomery
AL
ALABAMA
36106
Director
Thomas
A
Main
302 Prairie Street
Union Springs
AL
ALABAMA
36089
Director
Charles
T
Smith
23355 Fifth Avenue
Florala
AL
ALABAMA
36442
Director
Pharmaceuticals
No Revenues
- 06b
false
true
false
true
false
25000
11500000
0
11500000
No sale has occurred yet.
false
0
0
0
1510000
true
Bryce Harvey owns the majority of interests in H2-Pharma,LLC, which loaned money to the issuer. $1,500,000 will be used to pay down principal of that loan. About $10,000 will be used to pay officers & directors interest on short term loans they made.
false
Vitruvias Therapeutics, Inc.
Carl L. Whatley, Jr.
Carl L. Whatley, Jr.
President
2017-12-20